METTL14 integrates tumor-derived SAM to drive parabrachial epigenetic rewiring in pancreatic cancer
Neuron · 2026-01 · 114 (2) · 250-267.e8
DOI: 10.1016/j.neuron.2025.10.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuron, 2026-01. Verfasst von Xiaohua Yang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen …. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, S-Adenosylmethionine, Methyltransferases, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 93 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Sun Yat-sen University Cancer Center, National Natural Science Foundation of China.
Abstract (Originalsprache)
Tumor-neural crosstalk drives cancer progression and neurological symptoms, yet how tumors rewire brain circuits remains unclear. Here, we identified upregulated methyltransferase-like 14 (METTL14) in lateral parabrachial nucleus glutamatergic neurons (LPBNGlu) as a key regulator of pain-depression comorbidity in pancreatic ductal adenocarcinoma (PDAC) mice. METTL14 inhibition reversed PDAC-induced neuronal hyperexcitability and alleviated behavioral deficits. Mechanistically, METTL14 coordinated the tumor-derived S-adenosylmethionine (SAM) to promote N6-methyladenosine (m6A) modification of adrenomedullin (ADM) mRNA, enhancing neuronal hyperactivation and potentiating LPBNGlu projections to the paraventricular thalamus (PVT) and lateral hypothalamus (LH). ADM suppression and chemogenetic or optogenetic silencing of LPBNGlu → PVTGlu/LHGlu circuits significantly mitigated comorbidity. Moreover, elevated circulating SAM in PDAC patients and mice amplifies this pathway. A methionine-restricted diet (MRD) reduced SAM levels, mitigating comorbidity and suppressing tumor growth. Our findings unveil the SAM-METTL14-ADM axis and LPBNGlu → PVTGlu/LHGlu neurocircuits in PDAC-induced brain remodeling, positioning MRD as a promising therapeutic strategy to improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China; Guangdong Prov…
- Department of Anesthesiology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.
- Guangdong Province Key Laboratory of Brain Function and Disease, Department of Physiology and Pain Research Center, Zhongshan School of Medicine, Sun Yat-sen University, 74 Zhongshan Road 2, Guangzhou 510080, P.R. China.
- Department of Anesthesiology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China. Electronic add…
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- Sun Yat-sen University Cancer Center
- National Natural Science Foundation of China
Zitieren
APA
Yang, X., Wang, X., Lu, W., Ye, Q., Li, Y., Ma, X., Ye, Y., Guo, X., Chen, G., Xin, W., Xu, T., Zeng, W., & Xie, J. (2026). METTL14 integrates tumor-derived SAM to drive parabrachial epigenetic rewiring in pancreatic cancer. Neuron, 114(2), 250-267.e8. https://doi.org/10.1016/j.neuron.2025.10.002
Vancouver
Yang X, Wang X, Lu W, Ye Q, Li Y, Ma X, et al. METTL14 integrates tumor-derived SAM to drive parabrachial epigenetic rewiring in pancreatic cancer. Neuron. 2026;114(2):250-267.e8. doi:10.1016/j.neuron.2025.10.002
BibTeX
@article{Yang2026,
author = {Yang, Xiaohua and Wang, Xintong and Lu, Weicheng and Ye, Qingqing and Li, Yongchun and Ma, Xinyu and Ye, Yaqi and Guo, Xiangna and Chen, Guojun and Xin, Wenjun and Xu, Ting and Zeng, Weian and Xie, Jingdun},
title = {METTL14 integrates tumor-derived SAM to drive parabrachial epigenetic rewiring in pancreatic cancer},
journal = {Neuron},
year = {2026},
volume = {114},
number = {2},
pages = {250--267.e8},
doi = {10.1016/j.neuron.2025.10.002}
}
EUVIMED